http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DD-218368-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_da9c519bc5d52cdf9e2c478e123d9f7b
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J7-00
filingDate 1983-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d58b13a17bef37c73b1311fead1d1ffe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_839c67c7b6920ad4ae387f381ae66a04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7897562bf325ad2fa2298c558dff7701
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a01285f558a8a9c216e4a881e06aa59c
publicationDate 1985-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DD-218368-A1
titleOfInvention PROCESS FOR THE PREPARATION OF 16 ALPHA, 17 ALPHA-CYCLOHEXENO-GONA-1,3,5 (10) DRIENES
abstract It describes the preparation of 16a, 17a-cyclohexeno-gona-1,3,5 (10) -trienes of the general formula I, the valuable intermediates, for. B. represent for the synthesis of hormonally active compounds. The compounds prepared by the process according to the invention are new. Their preparation is based on 17-acetyl-gona-1,3,5 (10), 16-tetraenen of the general formula II, which is obtained with a diene of the general formula CH2CR3-CR4CH2 (III) in a polar organic solvent in Reacting the presence of a Lewis acid catalyst.
priorityDate 1983-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6327
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID424963217
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24409
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412216270
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558575
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455858454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426065010
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452750076
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154088130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450459896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431916463
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21226440
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID785
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546766
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10566
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419523826
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426105809
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5272653
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8000
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID450201584
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID86738798
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21880519

Total number of triples: 38.